CLINICAL TRIALS PROFILE FOR EZETIMIBE AND SIMVASTATIN
✉ Email this page to a colleague
All Clinical Trials for EZETIMIBE AND SIMVASTATIN
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00079638 ↗ | Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL | Completed | Kos Pharmaceuticals | Phase 4 | 2004-04-01 | The purpose of this study is to evaluate the effectiveness of first-line treatment using Niaspan (an extended release version of niacin) and statins versus other drugs that lower lipid levels, in subjects with elevated fat levels in their blood (dyslipidemia). Statins are a class of medication that is often prescribed to patients who need to lower their cholesterol levels. |
| NCT00090298 ↗ | Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Drugs in Patients With Elevated Cholesterol Levels (0653A-058) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2004-04-01 | A 10-week study to compare the reduction in cholesterol following treatment with two different marketed drugs in patients with hypercholesterolemia. |
| NCT00092599 ↗ | Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-801) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2003-02-01 | This study will evaluate patients who have coronary heart disease to determine if an investigational drug will further lower cholesterol when taken in combination with an approved cholesterol lowering medication. |
| NCT00092612 ↗ | Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-802)(COMPLETED) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2003-05-01 | The purpose of this study is to investigate additional cholesterol lowering effects in patients with coronary heart disease by giving an investigational drug with a patient's current approved cholesterol lowering medication. |
| NCT00092651 ↗ | A Study of MK0653A (Ezetimibe (+) Simvastatin) in Patients With Hypercholesterolemia (0653A-038) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2002-09-01 | The purpose of this study is to evaluate the lipid lowering effects of an investigational drug in patients with hypercholesterolemia (high cholesterol). |
| NCT00092664 ↗ | An Extension Study of An Investigational Drug in Patients With Hypercholesterolemia (0653A-038)(COMPLETED) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2003-01-01 | The purpose of this study is to evaluate the lipid lowering effects of an investigational drug in patients with hypercholesterolemia (high cholesterol). |
| NCT00092677 ↗ | An Investigational Drug on Clinical Outcomes in Patients With Aortic Stenosis (Narrowing of the Major Blood Vessel of the Heart)(MK-0653A-043 AM4)(COMPLETED) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2001-01-01 | The purpose of this study is to evaluate whether treatment with an investigational drug as compared to placebo will reduce the risk of major cardiovascular events in patients with aortic stenosis. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for EZETIMIBE AND SIMVASTATIN
Condition Name
Clinical Trial Locations for EZETIMIBE AND SIMVASTATIN
Trials by Country
Clinical Trial Progress for EZETIMIBE AND SIMVASTATIN
Clinical Trial Phase
Clinical Trial Sponsors for EZETIMIBE AND SIMVASTATIN
Sponsor Name
